Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vivos Therapeutics

5.73
-0.3400-5.60%
Post-market: 6.000.2700+4.71%19:25 EDT
Volume:299.15K
Turnover:1.77M
Market Cap:33.75M
PE:-3.36
High:6.46
Open:6.21
Low:5.71
Close:6.07
Loading ...
Jun 13, 2025

Major Issues Report

Form 8-K - Current report
Jun 06, 2025

Major Issues Report

Form 8-K - Current report
May 23, 2025

Major Issues Report

Form 8-K - Current report
May 16, 2025

Major Issues Report

Form 8-K - Current report
May 16, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 17, 2025

Major Issues Report

Form 8-K - Current report
Mar 31, 2025

Major Issues Report

Form 8-K - Current report
Mar 31, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 14, 2025

Major Issues Report

Form 8-K - Current report
Jan 29, 2025

Correspondence

Form CORRESP - Correspondence
Jan 29, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jan 22, 2025

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Dec 23, 2024

Major Issues Report

Form 8-K - Current report
Nov 27, 2024

Major Issues Report

Form 8-K - Current report
Nov 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 15, 2024

Major Issues Report

Form 8-K - Current report
Nov 15, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Sep 24, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Sep 20, 2024

Major Issues Report

Form 8-K - Current report